Skip to main content Accessibility help
  • Print publication year: 2010
  • Online publication date: December 2010

94 - Tizanidine

from Section 10 - Muscle Relaxants


2. HenneyHR, RunyanDJ. A clinically relevant review of Tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and dose effectiveness in healthy subjects and patients. Int J Clin Pract 2008;62(2):314–324.
3. WagstaffAJ, BrysonHM. Tizanidine: a review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs 1997;53(3):435–452.
4. NancePW, SheremataWA, LynchSG, et al. Relationship of the antispasticity effect of Tizanidine to plasma concentration in patients with multiple sclerosis. Arch Neurol 1997;54:731–736.
5. Chou, et al. J Pain Symptom Manage 2004;28(2):141–175.
6.Cost taken from